MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 205 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2022. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $524,394 | -34.1% | 15,790 | -37.4% | 0.00% | 0.0% |
| Q3 2022 | $796,000 | -49.7% | 25,230 | -51.5% | 0.00% | -50.0% |
| Q2 2022 | $1,583,000 | +16.6% | 52,065 | -0.5% | 0.00% | 0.0% |
| Q1 2022 | $1,358,000 | +37.6% | 52,321 | +8.1% | 0.00% | +100.0% |
| Q4 2021 | $987,000 | -18.9% | 48,380 | -23.5% | 0.00% | -50.0% |
| Q3 2021 | $1,217,000 | -26.2% | 63,230 | -15.0% | 0.00% | 0.0% |
| Q2 2021 | $1,650,000 | +54.1% | 74,396 | +82.3% | 0.00% | 0.0% |
| Q1 2021 | $1,071,000 | +79.1% | 40,802 | +27.6% | 0.00% | +100.0% |
| Q4 2020 | $598,000 | +25.6% | 31,980 | +14.0% | 0.00% | 0.0% |
| Q3 2020 | $476,000 | -2.7% | 28,060 | +1.3% | 0.00% | -50.0% |
| Q4 2016 | $489,000 | +61.9% | 27,690 | +76.9% | 0.00% | +100.0% |
| Q3 2016 | $302,000 | +2.7% | 15,651 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $294,000 | -2.6% | 15,075 | +3.0% | 0.00% | -50.0% |
| Q1 2016 | $302,000 | – | 14,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |